🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,39 USD

Máx. histórico

119,27

4269 días

Caída desde máximo

-69,49%

Rango 52 semanas

18,80 – 36,67

Variación hoy

-0,03%

Cierre anterior

36,40

Rango de hoy

36,39 – 36,41

Volumen hoy

1.075.323

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
103,97 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 5 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
17/01/2025 22,05 22,67 21,50 22,36 +1,36% 5,31% 930.300
16/01/2025 21,88 22,44 21,25 22,06 +0,82% 5,44% 779.200
15/01/2025 20,74 22,20 20,33 21,88 +6,47% 9,02% 813.600
14/01/2025 21,12 21,41 20,33 20,55 -2,74% 5,11% 690.200
13/01/2025 21,01 21,97 20,08 21,13 +2,37% 9,00% 1.179.800
10/01/2025 20,14 22,36 19,81 20,64 +11,09% 12,66% 1.678.300
08/01/2025 18,55 18,84 18,18 18,58 -0,54% 3,56% 394.400
07/01/2025 18,80 19,16 18,40 18,68 +0,27% 4,04% 596.200
06/01/2025 18,40 19,16 18,17 18,63 +1,25% 5,38% 581.900
03/01/2025 18,50 18,86 18,34 18,40 +0,38% 2,81% 428.400
02/01/2025 19,05 19,45 18,27 18,33 -2,71% 6,19% 630.900
31/12/2024 18,99 19,43 18,80 18,84 -0,53% 3,32% 409.400
30/12/2024 19,40 19,70 18,89 18,94 -3,61% 4,18% 413.900
27/12/2024 19,82 20,04 19,47 19,65 -0,81% 2,88% 408.400
26/12/2024 19,36 19,86 19,25 19,81 +1,75% 3,15% 474.300
24/12/2024 19,25 19,49 18,93 19,47 +1,41% 2,91% 269.900
23/12/2024 19,08 19,66 18,96 19,20 +1,16% 3,67% 905.000
20/12/2024 19,07 19,80 18,73 18,98 -3,01% 5,61% 3.169.900
19/12/2024 19,17 19,71 19,06 19,57 +1,98% 3,39% 863.000
18/12/2024 19,76 20,34 19,10 19,19 -3,23% 6,28% 585.700
17/12/2024 19,72 20,01 19,33 19,83 -0,20% 3,45% 690.300
16/12/2024 19,46 20,27 19,14 19,87 +0,05% 5,81% 702.900
13/12/2024 19,76 19,91 18,73 19,86 +0,30% 5,97% 605.500
12/12/2024 20,08 20,42 19,76 19,80 -2,61% 3,29% 600.400
11/12/2024 19,85 20,40 19,40 20,33 +2,88% 5,04% 681.000
10/12/2024 19,25 19,85 18,76 19,76 +3,51% 5,66% 1.097.700
09/12/2024 19,30 19,81 18,82 19,09 -0,93% 5,13% 949.800
06/12/2024 18,67 19,40 18,67 19,27 +3,21% 3,91% 1.595.000
05/12/2024 19,34 19,54 18,54 18,67 -2,20% 5,17% 1.167.100
04/12/2024 16,71 19,49 16,64 19,09 +14,45% 17,06% 1.655.500